Epic Systems is moving to ease the way artificial intelligence companies read data held in its electronic health record platforms, while rejecting claims that its practices limit competition in the health technology market. Executives from Epic Systems addressed the issue on Wednesday during a panel at HLTH, the health technology conference in Las Vegas.
The company, widely regarded as the largest provider of electronic health records, sits at the center of a digital infrastructure used by hospitals, clinics and software developers across the United States. Its systems contain records on more than 280 million Americans, making access to that information a decisive issue for companies building clinical, administrative and artificial intelligence tools for health care providers.
The remarks marked a direct public response from Epic leadership to allegations that the company has selectively limited data access required by competing application developers. Epic executives defended the company’s policies and presented the planned changes as part of an effort to create a more open ecosystem. They also pointed to the operational strain created by a large volume of integration requests from outside vendors seeking to connect with Epic platforms.
Seth Howard, Epic’s executive vice president of research and development, said the company received about 75,000 inquiries last year from organizations looking to use or connect with its data systems. His comments underscored a central challenge for digital health infrastructure: balancing broad interoperability with the technical work involved in linking third-party applications to records that are often used in clinical decision-making and patient care.
The commitment to make AI access easier comes as hospitals and software vendors race to deploy tools that can summarize charts, identify risks and automate administrative tasks. For developers, the value of such products depends heavily on reliable access to structured and unstructured health data. For Epic, the debate places its role in health technology under closer scrutiny, as questions about competition, interoperability and control over patient information become increasingly important to the future of digital medicine.
